Otsuka Pharmaceutical Development & Commercialization, Inc.
4
Boehringer Ingelheim
2
Cephalon
2
Janssen Research & Development, LLC
2
Novartis
2
Novartis Pharmaceuticals
2
Pfizer
2
ACADIA Pharmaceuticals Inc.
1
Assurex Health Inc.
1
Bial - Portela C S.A.
1
Clinical Trials at Viking Clinical Research
During the past decade, Viking Clinical Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 16 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
2010-06-01
2011-10-01
Terminated
837
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Viking Clinical Research" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 6 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Cephalon" with 2 trials sponsored and "Janssen Research & Development, LLC"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Viking Clinical Research"
#1 collaborator was "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "Sunovion" with 1 trials as a collaborator, "University of Michigan" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Viking Clinical Research
According to Clinical.Site data, the most researched conditions in "Viking Clinical Research" are
"Depressive Disorder, Major" (9 trials), "Depression" (3 trials), "Major Depressive Disorder" (3 trials), "Borderline Personality Disorder" (2 trials) and "Major Depressive Disorder (MDD)" (2 trials). Many other conditions were trialed in "Viking Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Viking Clinical Research
Most popular intervention types in "Viking Clinical Research" are "Drug" (28 trials), "Other" (4 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Rapastinel" (6 trials), "placebo" (3 trials), "Armodafinil" (2 trials) and "Aticaprant" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Viking Clinical Research
The vast majority of trials in "Viking Clinical Research" are
29 trials for "All" genders.
Clinical Trials Status at Viking Clinical Research
Currently, there are NaN active trials in "Viking Clinical Research".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Viking Clinical Research,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Viking Clinical Research, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 1 trials that are defined as “Not Applicable".